triazoles has been researched along with micafungin in 112 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 44 (39.29) | 29.6817 |
2010's | 65 (58.04) | 24.3611 |
2020's | 3 (2.68) | 2.80 |
Authors | Studies |
---|---|
Chiou, CC; Groll, AH; Walsh, TJ | 1 |
Habel, F; Hoban, D; Laverdiere, M; Restieri, C | 1 |
Hori, Y; Kohno, S; Matsumori, H; Miyazaki, Y; Mizukane, R; Ohya, S; Sawae, Y; Takesako, K; Uchida, K; Yamaguchi, H; Yoshida, M | 1 |
Mori, T | 1 |
Avila, NA; Bacher, J; Casler, HE; Groll, AH; Kelaher, AM; Lyman, CA; Petraitiene, R; Petraitis, V; Sarafandi, AA; Sein, T; Walsh, TJ | 1 |
Fujihara, N; Ichiyama, S; Iinuma, Y; Kudo, T; Saito, T; Takakura, S | 1 |
Kamei, K; Nishimura, K; Zeng, J; Zheng, Y | 1 |
Chandrasekar, PH; Cutright, JL; Manavathu, EK | 1 |
Espinel-Ingroff, A | 1 |
Marr, K | 1 |
Steinbach, WJ | 1 |
Fernández-Torres, B; Guarro, J; Lazéra, Mdos S; Nolard, N; Pastor, FJ; Serena, C; Trilles, L | 1 |
Benjamin, DK; Steinbach, WJ; Zaoutis, TE | 1 |
Kontoyiannis, DP; Lewis, RE | 1 |
Niwa, T; Shiraga, T; Takagi, A | 1 |
Baker, CJ; Pannaraj, PS; Walsh, TJ | 1 |
Ballentine, CS; Glickman, RD; Graybill, JR; Harrison, JM; Kumar, N; Kurian, P; Lloyd, WC; Melendez, R; Miller, A; Miller, MM; Najvar, LK; Paris, G; Patel, AH; Pena, MA; Sponsel, WE; Trigo, Y; Trujillo, F | 1 |
Clemons, KV; Espiritu, M; Parmar, R; Stevens, DA | 1 |
Heyn, K; Müller, FM; Salvenmoser, S; Tredup, A | 1 |
Chamilos, G; Kontoyiannis, DP | 1 |
Asada, N; Komatsu, M; Koseki, M; Matsue, K; Takeuchi, M; Uryu, H | 1 |
Kadota, J; Tokimatsu, I | 1 |
Aperis, G; Mylonakis, E; Spanakis, EK | 1 |
Cano, J; Gené, J; Gilgado, F; Guarro, J; Serena, C | 1 |
Alak, A; Buell, D; Holum, M; Keirns, J; Sawamoto, T; Wisemandle, W | 1 |
Maesaki, S | 2 |
Benjamin, DK; Jafri, HS; Mejias, A; Patel, S; Sánchez, PJ; Santos, RP; Walsh, TJ | 1 |
Guarro, J; Mariné, M; Pastor, FJ; Rodríguez, MM; Serena, C | 1 |
Aoun, N; Baixench, MT; Bretagne, S; Dannaoui, E; Desnos-Ollivier, M; Garcia-Hermoso, D; Piketty, C; Ramires, S | 1 |
Hosoki, T; Ikuta, K; Jimbo, J; Kohgo, Y; Nishimura, K; Sano, A; Sato, K; Shindo, M; Torimoto, Y | 1 |
Fujita, M; Harada, E; Ikegame, S; Inoshima, I; Nakanishi, Y; Ouchi, H | 1 |
Scheinfeld, N | 1 |
Mercier, RC; Pai, MP; Samples, ML; Spilde, MN | 1 |
Chu, CC; Hsueh, PR; Ruan, SY | 1 |
Guarro, J; Mariné, M; Ruíz-Cendoya, M | 1 |
Gafter-Gvili, A; Goldberg, E; Leibovici, L; Paul, M; Vidal, L | 1 |
Niimi, K; Niimi, M; Tanabe, K | 1 |
Fujii, Y; Inase, N; Yoshizawa, Y | 1 |
Guarro, J; Mariné, M; Pastor, FJ | 1 |
Calvo, E; Guarro, J; Mariné, M; Pastor, FJ; Rodríguez, MM; Serena, C | 1 |
Asari, S; Iwatani, Y; Nishi, I; Sunada, A; Toyokawa, M | 1 |
Baggen, L; Chisholm, J; Sharland, M; Thomas, L | 1 |
Imamura, Y; Kaneko, Y; Kohno, S; Miyazaki, Y; Ohno, H | 1 |
Fukazawa, H; Imamura, Y; Kaneko, Y; Kohno, S; Miyazaki, Y; Murakami, Y; Ohno, H | 1 |
Choi, JH; Choi, SM; Kwon, EY; Lee, DG; Park, CM; Shin, WS; Stevens, DA; Yoo, JH | 1 |
Furuya, A; Ida, K; Kato, M; Koh, K; Okamoto, T; Takita, J | 1 |
Akashi, K; Aoki, T; Harada, N; Iwasaki, H; Kamezaki, K; Miyamoto, T; Mori, Y; Nagafuji, K; Shimono, N; Takenaka, K; Teshima, T; Yamauchi, T; Yoshimoto, G | 1 |
Arnold, TM; Dotson, E; Hage, CA; Sarosi, GA | 1 |
Beresford, E; Krishna, G; Ma, L; Medlock, M; Noren, C; Power, E; Vickery, D; Yu, X | 1 |
Higashimoto, I; Koreeda, Y; Mataki, H; Matsuda, T; Noma, S; Taira, T | 1 |
Cordonnier, C; Cornely, OA; Flückiger, U; Frêre, P; Gachot, B; Heinz, WJ; Herbrecht, R; Lass-Flörl, C; Maertens, J; Marchetti, O; Ribaud, P; Thiebaut, A | 1 |
Amitani, R; Izumikawa, K; Kakeya, H; Kohno, S; Kurashima, A; Miyazaki, Y; Niki, Y; Ogawa, K; Okimoto, N | 1 |
Abe, M; Fujii, S; Harada, T; Jinno, T; Kagawa, K; Matsumoto, T; Miki, H; Nakamura, S; Nakano, A; Ozaki, S; Takeuchi, K; Yata, K | 1 |
Gyo, K; Hato, N; Hinohira, Y; Hyodo, J; Takahashi, H; Ugumori, T; Wakisaka, H | 1 |
Andes, D; Bastulli, C; Chaturvedi, V; Diekema, DJ; Ghannoum, MA; Iqbal, N; Knapp, C; Lockhart, SR; Marchillo, K; Messer, S; Ostrosky-Zeichner, L; Paetznick, VL; Pfaller, MA; Ramani, R; Rodriguez, J; Sein, T; Walsh, TJ; Welshenbaugh, AR | 1 |
Garnacho-Montero, J; Jiménez Parrilla, F | 1 |
Ruiz-Camps, I | 1 |
Jarque, I; Salavert, M | 1 |
Diekema, DJ; Ledeboer, NA; Peterson, JF; Pfaller, MA; Riebe, KM; Rinaldi, MG | 1 |
Clemons, KV; Schwartz, JA; Stevens, DA | 1 |
Baltch, AL; Bopp, LH; Michelsen, PB; Ritz, W; Smith, RP | 1 |
Beiras-Fernandez, A; Bigdeli, AK; Kaczmarek, I; Michel, S; Nickel, T; Reichart, B; Ueberfuhr, P | 1 |
Abe, S; Asada, M; Hata, K; Horii, T; Inoue, S; Matsukura, M; Miyazaki, M; Murai, N; Nakamoto, K; Shirotori, S; Tanaka, K; Watanabe, NA; Yoshimatsu, K | 1 |
Hirano, K; Hosogaya, N; Ide, S; Imamura, Y; Iwanaga, N; Izumikawa, K; Kakeya, H; Kohno, S; Kurihara, S; Mihara, T; Minematsu, A; Miyazaki, T; Morinaga, Y; Nakamura, S; Nishino, T; Takazono, T; Tashiro, M; Tashiro, T; Tsukamoto, M; Yamamoto, Y; Yanagihara, K; Yasuoka, A | 1 |
Labbé, AC; Laverdière, M; Levallois, J; Nadeau-Fredette, AC; Ouimet, D; Vallée, M | 1 |
Curfs-Breuker, I; de Hoog, GS; Klaassen, CH; Lackner, M; Meis, JF; Najafzadeh, MJ; Verweij, PE | 1 |
Fortún, J | 1 |
Dukhan, A; Paderu, P; Park, S; Perlin, DS; Senter, M; Zhao, Y | 1 |
Alves, SH; Antunes, MS; Bandeira, LA; Denardi, LB; Mario, DA; Santurio, JM; Severo, LC | 1 |
Feng, G; Li, J; Liu, W; Pang, X; Shang, W; Sun, R; Wang, X; Wang, Y; Zhang, S; Zhang, W | 1 |
Baden, LR; Boukedes, S; Camp, PC; Dietzek, A; Fuhlbrigge, AL; Goldberg, HJ; Issa, NC; Koo, S; Kubiak, DW; Marty, FM | 1 |
Ahmed, S; de Hoog, GS; Feng, P; Klaassen, CH; Lai, W; Lu, C; Meis, JF; Najafzadeh, MJ; Sun, J; Xi, L | 1 |
Fernandez, JF; Maselli, DJ; Restrepo, MI; Simpson, T | 1 |
Yoshida, M | 1 |
Gibas, CF; Malejczyk, K; Sigler, L; Smith, SW | 1 |
Li, R; Mu, X; Yu, J | 1 |
Badali, H; Curfs-Breuker, I; de Hoog, GS; Deng, S; Liao, W; Meis, JF; Najafzadeh, MJ; Pan, B; Yang, L | 1 |
Furuya, N; Mano, Y; Morishige, H; Oguri, T | 1 |
Curfs-Breuker, I; de Hoog, GS; Feng, P; Meis, JF; Najafzadeh, MJ; Rezaei-Matehkolaei, A; Saradeghi Keisari, M; Shamsian, SA; Vicente, VA | 1 |
Hirose, Y; Kokuzawa, S; Mochizuki, K; Suemori, S; Yaguchi, T | 1 |
Akata, K; Aoki, T; Fujii, M; Hisaoka, M; Ishimoto, H; Kawanami, T; Kinoshita, S; Korogi, Y; Mukae, H; Yatera, K | 1 |
Chang, CY; Chen, KH; Hou, JY; Huang, TH; Liang, DC; Liu, HC; Yeh, TC | 1 |
Bangard, C; Cornely, OA; Shimabukuro-Vornhagen, A; Tran, L; Vehreschild, JJ; Vehreschild, MJ; von Bergwelt-Baildon, M; Wisplinghoff, H | 1 |
Fernández-Silva, F; Guarro, J; Lackner, M; Lass-Flörl, C | 1 |
Angelova, O; Auberger, J; Ditlbacher, A; Lackner, M; Lass-Flörl, C; Nachbaur, D; Orth-Höller, D | 1 |
Fouant, MM; Katragkou, A; Kovanda, LL; McCarthy, M; Meletiadis, J; Moradi, PW; Petraitiene, R; Petraitis, V; Roilides, E; Strauss, GE; Walsh, TJ | 1 |
Al-Hatmi, AM; Bonifaz, A; de Hoog, GS; Garcia-Carmona, K; Meis, JF; van Diepeningen, AD; Vazquez-Maya, L | 1 |
Alves, SH; Ferreiro, L; Jesus, FP; Pilotto, MB; Pötter, L; Santurio, JM; Weiblen, C; Zanette, RA | 1 |
Benjamin, DK; Botero-Calderon, L; Cohen-Wolkowiez, M | 1 |
Castanheira, M; Jones, RN; Messer, SA; Pfaller, MA; Rhomberg, PR | 1 |
Chowdhary, A; Curfs-Breuker, I; de Hoog, GS; Hagen, F; Madrid, H; Meis, JF | 1 |
Hall, RG; Payne, KD | 1 |
Carlson, D; Mattioni, J; Moore, JE; Portnoy, JE; Sataloff, RT | 1 |
Lanternier, FL; Lortholary, O; Pilmis, B | 1 |
Aarnoutse, RE; Brüggemann, RJ; Burger, DM; Koenderink, JB; Lempers, VJ; Russel, FG; van den Heuvel, JJ | 1 |
Legendre, DP; Muzny, CA; Riley, TT; Swiatlo, E | 1 |
Biehl, LM; Bücker, V; Cornely, OA; Franke, B; Liss, B; Markiefka, B; Persigehl, T; Scheid, C; Vehreschild, JJ; Vehreschild, MJ; Wisplinghoff, H | 1 |
Alqarihi, A; Azie, N; Edwards, JE; Gebremariam, T; Ibrahim, AS; Uppuluri, P; Wiederhold, NP | 1 |
Hussain, K; Katragkou, A; Kovanda, LL; McCarthy, M; Meletiadis, J; Moradi, PW; Myint, KL; Petraitiene, R; Petraitis, V; Roilides, E; Strauss, GE; Walsh, TJ; Zaw, MH | 1 |
Arthur, I; Baird, R; Bak, N; Blyth, C; Botes, J; Chapman, B; Chen, S; Cheong, E; Cooley, L; George, CR; Goeman, E; Hajkowicz, K; Halliday, C; Heath, CH; Hofmeyr, A; Kalukottege, P; Keighley, C; Kennedy, K; Kesson, A; Kidd, S; Korman, TM; Leung, M; Liu, E; Macesic, N; Marriott, D; McMullan, B; Morrissey, CO; Pendle, S; Robson, J; Slavin, M; Sorrell, TC; Underwood, N; van Hal, S; Weeks, K | 1 |
Hope, WW; Hussain, K; Kovanda, LL; Maung, BBW; McCarthy, MW; Petraitiene, R; Petraitis, V; Sekhon, NK; Shaikh, N; Walsh, TJ; Zaw, MH | 1 |
Ho, CL; Lee, CH; Lin, C; Lin, JC; Sun, M; Yen, WT | 1 |
Badali, H; Chowdhary, A; Dannaoui, E; Fakhim, H; Meis, JF; Prakash, A; Vaezi, A | 1 |
Courbin, V; Dannaoui, E; Jullien, V; Raffetin, A | 1 |
Chen, J; Qian, L; Shen, J; Yang, X; Zhang, Y | 1 |
Berman, E; Epstein, DJ; Frattini, MG; Huang, YT; Klimek, VM; Papanicolaou, GA; Park, JH; Seo, SK; Tallman, MS | 1 |
Kwa, LHA; Lee, HLW; Lim, TP; Tan, BH; Tan, SYM; Tan, TT; Tang, SLS; Wong, GC; Zhou, PY | 1 |
Ataollahy, N; Hammarström, H; Kondori, N; Lindberg, E | 1 |
Demmler-Harrison, GJ; Dinu, D; Fatemizadeh, R; Rodman, E | 1 |
Bae, NY; Byun, JM; Choe, PG; Kang, CK; Kim, MS; Kim, NJ; Park, KJ; Yoon, SS | 1 |
Meng, XX; Su, CZ; Su, F; Zhang, JL | 1 |
28 review(s) available for triazoles and micafungin
Article | Year |
---|---|
New drugs and novel targets for treatment of invasive fungal infections in patients with cancer.
Topics: Anidulafungin; Antifungal Agents; Echinocandins; Humans; Immunocompromised Host; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Neoplasms; Opportunistic Infections; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2000 |
[Issues in the development of drugs for treating deep-seated mycosis].
Topics: Animals; Antifungal Agents; Clinical Trials as Topic; Depsipeptides; Drug Approval; Drug Design; Echinocandins; Glucosyltransferases; Hexosyltransferases; Humans; Lipopeptides; Lipoproteins; Micafungin; Peptides, Cyclic; Structure-Activity Relationship; Triazoles | 2002 |
[Aspergillosis].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; beta-Glucans; Biomarkers; Diagnosis, Differential; Echinocandins; Glucans; Humans; Lipopeptides; Lipoproteins; Micafungin; Peptides, Cyclic; Pyrimidines; Serologic Tests; Triazoles; Voriconazole | 2003 |
In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature.
Topics: Anidulafungin; Antifungal Agents; Echinocandins; Fungi; Humans; Lipopeptides; Lipoproteins; Micafungin; Mycology; Peptides, Cyclic; Triazoles | 2003 |
Combination antifungal therapy: where are we now, and where are we going?
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Azoles; Candidiasis; Caspofungin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; In Vitro Techniques; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Pyrimidines; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Antifungal agents in children.
Topics: Age Factors; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Child; Clinical Trials as Topic; Drug Approval; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Patient Selection; Pediatrics; Peptides, Cyclic; Pyrimidines; Safety; Thiazoles; Triazoles; United States; Voriconazole | 2005 |
Antifungal treatment in pediatric patients.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Azoles; Caspofungin; Child; Child, Preschool; Drug Resistance, Fungal; Echinocandins; Flucytosine; Fungal Proteins; Humans; Infant; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Triazoles | 2005 |
[Drug-drug interaction of antifungal drugs].
Topics: Antifungal Agents; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Echinocandins; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Lipopeptides; Lipoproteins; Micafungin; Miconazole; Microsomes, Liver; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2005 |
Update on antifungal drug resistance mechanisms of Aspergillus fumigatus.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Naphthalenes; Peptides, Cyclic; Terbinafine; Triazoles | 2005 |
[Efficacies and clinical roles of new antifungal agents].
Topics: Antifungal Agents; Aspergillosis; Caspofungin; Echinocandins; Humans; Lipopeptides; Lipoproteins; Micafungin; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2006 |
New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Clinical Trials as Topic; Cryptococcosis; Echinocandins; Fever; Humans; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Neutropenia; Peptides, Cyclic; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2006 |
[The future of antifungal agents].
Topics: Amphotericin B; Animals; Antifungal Agents; Drug Therapy; Echinocandins; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Pyrimidines; Stem Cell Transplantation; Triazoles; Voriconazole | 2007 |
[New development in the treatment of deep-seated mycoses].
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Echinocandins; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2007 |
A review of the new antifungals: posaconazole, micafungin, and anidulafungin.
Topics: Administration, Oral; Anidulafungin; Antifungal Agents; Dermatomycoses; Echinocandins; Humans; Infusions, Intravenous; Lipopeptides; Lipoproteins; Micafungin; Triazoles | 2007 |
Treatment of invasive candidal infections: systematic review and meta-analysis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Confidence Intervals; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Odds Ratio; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2008 |
[What's new in the molecular basis of antifungal drug resistance in pathogenic yeasts].
Topics: Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Candida; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Echinocandins; Fluconazole; Glucosyltransferases; Humans; Lipopeptides; Micafungin; Mutation; Pyrimidines; Saccharomyces cerevisiae Proteins; Sterols; Trans-Activators; Triazoles; Voriconazole | 2008 |
[Clinical efficacies of antifungal injections].
Topics: Amphotericin B; Antifungal Agents; Drug Delivery Systems; Echinocandins; Fluconazole; Humans; Infusions, Intravenous; Injections; Itraconazole; Lipopeptides; Liposomes; Micafungin; Mycoses; Organophosphates; Pyrimidines; Triazoles; Voriconazole | 2008 |
Diagnosis and treatment of aspergillosis in children.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Child; Echinocandins; Fungal Vaccines; Genomics; Humans; Immunocompromised Host; Lipopeptides; Micafungin; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2009 |
Traditional and emerging antifungal therapies.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Micafungin; Pyrimidines; Triazoles; Voriconazole | 2010 |
[Drug interactions in critically-ill patients. An important factor in the use of micafungin?].
Topics: Adult; Amphotericin B; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Child; Critical Illness; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Therapy, Combination; Echinocandins; Humans; Infant, Newborn; Lipopeptides; Micafungin; Microsomes, Liver; Mycoses; Triazoles | 2011 |
[Combination therapy for invasive aspergillosis].
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Caspofungin; Clinical Trials as Topic; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Echinocandins; Forecasting; Fungemia; Guinea Pigs; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Meningitis, Fungal; Micafungin; Mice; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Retrospective Studies; Triazoles | 2011 |
[Is micafungin useful in the prophylaxis of invasive fungal disease in hematological patients?].
Topics: Adult; Ambulatory Care; Antifungal Agents; Chemical and Drug Induced Liver Injury; Child; Clinical Trials as Topic; Dose-Response Relationship, Drug; Echinocandins; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Kidney Diseases; Lipopeptides; Male; Meta-Analysis as Topic; Micafungin; Mycoses; Postoperative Complications; Practice Guidelines as Topic; Triazoles | 2011 |
Ten-year experience with fungal peritonitis in peritoneal dialysis patients: antifungal susceptibility patterns in a North-American center.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Candida; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Follow-Up Studies; Humans; Itraconazole; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Mycoses; North America; Peritoneal Dialysis; Peritonitis; Pyrimidines; Triazoles; Voriconazole | 2012 |
[Antifungal therapy update: new drugs and medical uses].
Topics: Anidulafungin; Antifungal Agents; Aspergillosis; Candidiasis; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Early Diagnosis; Echinocandins; Humans; Immunocompromised Host; Lipopeptides; Micafungin; Mycoses; Randomized Controlled Trials as Topic; Salvage Therapy; Treatment Outcome; Triazoles | 2011 |
Advances in the treatment of invasive neonatal candidiasis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis, Invasive; Deoxycholic Acid; Drug Combinations; Echinocandins; Humans; Infant, Newborn; Lipopeptides; Micafungin; Triazoles | 2015 |
Dosing of antifungal agents in obese people.
Topics: Amphotericin B; Antifungal Agents; Candidiasis, Invasive; Caspofungin; Echinocandins; Fluconazole; Humans; Lipopeptides; Micafungin; Mycoses; Nitriles; Obesity; Pyridines; Triazoles | 2016 |
Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Debridement; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Male; Micafungin; Middle Aged; Mucorales; Mucormycosis; Nitriles; Pyridines; Triazoles; Virulence | 2016 |
Efficacy and safety of micafungin versus extensive azoles in the prevention and treatment of invasive fungal infections for neutropenia patients with hematological malignancies: A meta-analysis of randomized controlled trials.
Topics: Adolescent; Adult; Antifungal Agents; Child; Echinocandins; Female; Humans; Leukemia; Lipopeptides; Male; Micafungin; Middle Aged; Mycoses; Neutropenia; Randomized Controlled Trials as Topic; Triazoles | 2017 |
6 trial(s) available for triazoles and micafungin
Article | Year |
---|---|
Steady-state pharmacokinetics of micafungin and voriconazole after separate and concomitant dosing in healthy adults.
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Echinocandins; Female; Humans; Lipopeptides; Lipoproteins; Male; Micafungin; Middle Aged; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2007 |
Lack of pharmacokinetic drug interaction between oral posaconazole and caspofungin or micafungin.
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Area Under Curve; Caspofungin; Drug Interactions; Echinocandins; Female; Humans; Infusions, Intravenous; Lipopeptides; Male; Micafungin; Triazoles; Young Adult | 2011 |
Intravenous micafungin versus voriconazole for chronic pulmonary aspergillosis: a multicenter trial in Japan.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Aspergillus; Chronic Disease; Echinocandins; Female; Humans; Infusions, Intravenous; Japan; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Comparison of micafungin and voriconazole in the treatment of invasive fungal infections in kidney transplant recipients.
Topics: Adult; Aged; Antifungal Agents; China; Echinocandins; Female; Humans; Kidney Transplantation; Lipopeptides; Male; Micafungin; Middle Aged; Mycoses; Prospective Studies; Pyrimidines; Survival Rate; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2012 |
Feasibility and effectiveness of posaconazole prophylaxis in combination with micafungin bridging for patients undergoing allogeneic stem cell transplantation: a 6-yr analysis from the cologne cohort for neutropenic patients.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Antineoplastic Agents; Drug Therapy, Combination; Echinocandins; Female; Follow-Up Studies; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Injections, Intravenous; Lipopeptides; Male; Micafungin; Middle Aged; Mycoses; Neutropenia; Survival Analysis; Transplantation, Homologous; Treatment Outcome; Triazoles | 2014 |
Micafungin versus posaconazole prophylaxis in acute leukemia or myelodysplastic syndrome: A randomized study.
Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Antifungal Agents; Chemoprevention; Female; Humans; Incidence; Leukemia; Male; Micafungin; Middle Aged; Mycoses; Myelodysplastic Syndromes; Neutropenia; Survival Analysis; Treatment Failure; Triazoles | 2018 |
78 other study(ies) available for triazoles and micafungin
Article | Year |
---|---|
In vitro activity of three new triazoles and one echinocandin against Candida bloodstream isolates from cancer patients.
Topics: Antifungal Agents; Blood; Candida; Candidiasis; Echinocandins; Humans; In Vitro Techniques; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Neoplasms; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2002 |
Combination therapy in treatment of experimental pulmonary aspergillosis: synergistic interaction between an antifungal triazole and an echinocandin.
Topics: Animals; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Echinocandins; Female; Lipopeptides; Lipoproteins; Lung; Lung Diseases, Fungal; Micafungin; Organ Size; Peptides, Cyclic; Rabbits; Thiazoles; Triazoles | 2003 |
National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Echinocandins; Flucytosine; Humans; Itraconazole; Japan; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2004 |
Susceptibility of Pseudallescheria boydii and Scedosporium apiospermum to new antifungal agents.
Topics: Antifungal Agents; Echinocandins; Humans; Lipopeptides; Lipoproteins; Micafungin; Peptides, Cyclic; Pseudallescheria; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2004 |
Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Colony Count, Microbial; Disease Models, Animal; Drug Therapy, Combination; Echinocandins; Female; Guinea Pigs; Lipopeptides; Lipoproteins; Lung; Lung Diseases, Fungal; Micafungin; Peptides, Cyclic; Pyrimidines; Survival Analysis; Triazoles; Voriconazole | 2004 |
In vitro interactions of micafungin with other antifungal drugs against clinical isolates of four species of Cryptococcus.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus; Drug Interactions; Echinocandins; Humans; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Peptides, Cyclic; Triazoles | 2005 |
Micafungin in combination with voriconazole in Aspergillus species: a pharmacodynamic approach for detection of combined antifungal activity in vitro.
Topics: Antifungal Agents; Aspergillus; Drug Combinations; Echinocandins; Fluorescence; Fungal Proteins; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Microscopy, Fluorescence; Peptides, Cyclic; Pyrimidines; Staining and Labeling; Triazoles; Voriconazole | 2005 |
Advances in antifungal therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Animals; Antifungal Agents; Caspofungin; Child; Child, Preschool; Clinical Trials as Topic; Echinocandins; Fungal Proteins; Humans; Infant; Infant, Newborn; Lipopeptides; Lipoproteins; Micafungin; Middle Aged; Mycoses; Peptides, Cyclic; Pyrimidines; Thiazoles; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Retinal function assessed by ERG before and after induction of ocular aspergillosis and treatment by the anti-fungal, micafungin, in rabbits.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Echinocandins; Electroretinography; Endophthalmitis; Eye Infections, Fungal; Follow-Up Studies; Lipopeptides; Lipoproteins; Micafungin; Ophthalmoscopy; Peptides, Cyclic; Pyrimidines; Rabbits; Retina; Triazoles; Vitreous Body; Voriconazole | 2005 |
Comparative efficacies of conventional amphotericin b, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Caspofungin; Central Nervous System Fungal Infections; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Echinocandins; Lipopeptides; Lipoproteins; Liposomes; Micafungin; Mice; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2005 |
Effect of voriconazole combined with micafungin against Candida, Aspergillus, and Scedosporium spp. and Fusarium solani.
Topics: Antifungal Agents; Aspergillus; Candida; Drug Synergism; Drug Therapy, Combination; Echinocandins; Fusarium; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2005 |
Successful treatment of breakthrough Trichosporon asahii fungemia with voriconazole in a patient with acute myeloid leukemia.
Topics: Acute Disease; Antifungal Agents; Aspergillosis; Echinocandins; Fungemia; Humans; Leukemia, Myeloid; Lipopeptides; Lipoproteins; Male; Micafungin; Middle Aged; Mycoses; Peptides, Cyclic; Pyrimidines; Triazoles; Trichosporon; Voriconazole | 2006 |
Antifungal susceptibilities of the species of the Pseudallescheria boydii complex.
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Naphthalenes; Peptides, Cyclic; Pseudallescheria; Pyrimidines; Quality Control; Quinazolines; Scedosporium; Terbinafine; Thiazoles; Triazoles; Voriconazole | 2006 |
Successful medical treatment of cutaneous aspergillosis in a premature infant using liposomal amphotericin B, voriconazole and micafungin.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Dermatomycoses; Echinocandins; Humans; Infant, Extremely Low Birth Weight; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Lipopeptides; Lipoproteins; Micafungin; Peptides, Cyclic; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Combined therapies in a murine model of blastoschizomycosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Echinocandins; Flucytosine; Geotrichosis; Geotrichum; Humans; Immunocompromised Host; Lipopeptides; Lipoproteins; Male; Micafungin; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Survival Analysis; Triazoles; Trichosporon; Voriconazole | 2007 |
Acquired resistance to echinocandins in Candida albicans: case report and review.
Topics: Adult; Amino Acid Sequence; Amino Acid Substitution; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Genotype; HIV Infections; HIV-1; Humans; Lipopeptides; Lipoproteins; Male; Micafungin; Microbial Sensitivity Tests; Molecular Sequence Data; Peptides, Cyclic; Pyrimidines; Treatment Failure; Triazoles; Voriconazole | 2007 |
[Breakthrough pulmonary mucormycosis during voriconazole treatment after reduced-intensity cord blood transplantation for a patient with acute myeloid leukemia].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Cord Blood Stem Cell Transplantation; Echinocandins; Fatal Outcome; Graft vs Host Disease; Humans; Immunocompromised Host; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Lipopeptides; Lipoproteins; Lung Diseases, Fungal; Male; Micafungin; Middle Aged; Mucormycosis; Peptides, Cyclic; Pyrimidines; Transplantation Conditioning; Triazoles; Voriconazole | 2007 |
Successful treatment of refractory chronic necrotizing pulmonary aspergillosis with micafungin.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Chronic Disease; Drug Resistance, Multiple, Fungal; Echinocandins; Humans; Lipopeptides; Lipoproteins; Lung Diseases, Fungal; Male; Micafungin; Middle Aged; Necrosis; Pyrimidines; Radiography; Triazoles; Voriconazole | 2007 |
Activities and ultrastructural effects of antifungal combinations against simulated Candida endocardial vegetations.
Topics: Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Drug Therapy, Combination; Echinocandins; Endocarditis; Flucytosine; Humans; In Vitro Techniques; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Models, Biological; Pyrimidines; Triazoles; Voriconazole | 2008 |
In vitro susceptibilities of invasive isolates of Candida species: rapid increase in rates of fluconazole susceptible-dose dependent Candida glabrata isolates.
Topics: Anidulafungin; Antifungal Agents; Candida; Candida glabrata; Caspofungin; Echinocandins; Fluconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2008 |
Combined therapy in treatment of murine infection by Fusarium solani.
Topics: Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Drug Therapy, Combination; Echinocandins; Fusarium; Immunocompromised Host; Kidney; Lipopeptides; Lipoproteins; Male; Micafungin; Mice; Mycoses; Pyrimidines; Spleen; Survival Analysis; Triazoles; Voriconazole | 2008 |
Combined antifungal therapy in a murine model of disseminated infection by Cladophialophora bantiana.
Topics: Amphotericin B; Animals; Antifungal Agents; Ascomycota; Disease Models, Animal; Drug Therapy, Combination; Echinocandins; Flucytosine; Humans; Lipopeptides; Male; Micafungin; Mice; Mycoses; Treatment Outcome; Triazoles | 2009 |
Effects of double and triple combinations of antifungal drugs in a murine model of disseminated infection by Scedosporium prolificans.
Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Disease Models, Animal; Drug Resistance, Fungal; Drug Therapy, Combination; Echinocandins; Humans; Kidney; Lipopeptides; Male; Micafungin; Mice; Microbial Sensitivity Tests; Mycetoma; Pyrimidines; Scedosporium; Treatment Outcome; Triazoles; Voriconazole | 2009 |
In vitro antifungal combination effects of micafungin with fluconazole, voriconazole, amphotericin B, and flucytosine against clinical isolates of Candida species.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Synergism; Echinocandins; Fluconazole; Flucytosine; Humans; Lipopeptides; Micafungin; Pyrimidines; Triazoles; Voriconazole | 2009 |
The effects of an hsp90 inhibitor on the paradoxical effect.
Topics: Animals; Antifungal Agents; Candida albicans; Echinocandins; Enzyme Inhibitors; Fungi; HSP90 Heat-Shock Proteins; Lipopeptides; Macrolides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2009 |
Anti-Candida-biofilm activity of micafungin is attenuated by voriconazole but restored by pharmacological inhibition of Hsp90-related stress responses.
Topics: Antifungal Agents; Biofilms; Calcineurin; Candida albicans; Dose-Response Relationship, Drug; Echinocandins; Gene Expression Regulation, Fungal; HSP90 Heat-Shock Proteins; Lipopeptides; Micafungin; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Triazoles; Voriconazole | 2010 |
Immunomodulatory effects of antifungal agents on the response of human monocytic cells to Aspergillus fumigatus conidia.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Cell Line; Cell Survival; Echinocandins; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunologic Factors; Lipopeptides; Micafungin; Monocytes; Pyrimidines; Spores, Fungal; Triazoles; Tumor Necrosis Factor-alpha; Voriconazole | 2010 |
Voriconazole-micafungin combination therapy for acute lymphoblastic leukemia.
Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Candida tropicalis; Candidiasis; Drug Therapy, Combination; Echinocandins; Follow-Up Studies; Fungemia; Humans; Infant; Lipopeptides; Male; Micafungin; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Aspergillosis; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2010 |
Successful allogeneic stem cell transplantation in two patients with acute myelogenous leukaemia and invasive aspergillosis by antifungal combination therapy.
Topics: Amphotericin B; Antifungal Agents; Echinocandins; Female; Humans; Invasive Pulmonary Aspergillosis; Leukemia, Myeloid, Acute; Lipopeptides; Micafungin; Middle Aged; Pyrimidines; Stem Cell Transplantation; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole | 2011 |
A case of Aspergillus empyema successfully treated with combination therapy of voriconazole and micafungin: excellent penetration of voriconazole and micafungin into pleural fluid.
Topics: Aspergillus fumigatus; Drug Therapy, Combination; Echinocandins; Empyema, Pleural; Humans; Lipopeptides; Male; Micafungin; Middle Aged; Pleural Effusion; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2010 |
European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia; Lipopeptides; Micafungin; Mycoses; Neutropenia; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2011 |
[Multiple myeloma complicated with disseminated zygomycosis after bortezomib therapy].
Topics: Acidosis; Aged; Antifungal Agents; Antineoplastic Agents; Boronic Acids; Bortezomib; Echinocandins; Fatal Outcome; Humans; Lipopeptides; Male; Micafungin; Multiple Myeloma; Pyrazines; Pyrimidines; Triazoles; Tumor Lysis Syndrome; Voriconazole; Zygomycosis | 2010 |
Clinical features and outcomes of four patients with invasive fungal sinusitis.
Topics: Aged; Antifungal Agents; Aspergillosis; Biopsy; Blindness; Brain Infarction; Candidiasis; Cavernous Sinus; Combined Modality Therapy; Debridement; Early Diagnosis; Echinocandins; Fatal Outcome; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Lipopeptides; Magnetic Resonance Imaging; Male; Maxillary Sinusitis; Micafungin; Middle Aged; Orbit Evisceration; Orbital Diseases; Postoperative Complications; Pyrimidines; Sphenoid Sinusitis; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2011 |
Multilaboratory testing of two-drug combinations of antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida glabrata; Caspofungin; Drug Combinations; Echinocandins; Enzyme-Linked Immunosorbent Assay; Inhibitory Concentration 50; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2011 |
Multicenter comparison of the Vitek 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing caspofungin, micafungin, and posaconazole against Candida spp.
Topics: Antifungal Agents; Automation; Candida; Caspofungin; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Triazoles; United States | 2011 |
Therapeutic and toxicologic studies in a murine model of invasive pulmonary aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Caspofungin; Colony Count, Microbial; Deoxycholic Acid; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Echinocandins; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Micafungin; Mice; Mice, Inbred DBA; Pyrimidines; Triazoles; Voriconazole | 2011 |
Time-kill studies with micafungin and voriconazole against Candida glabrata intracellularly in human monocyte-derived macrophages and extracellularly in broth.
Topics: Antifungal Agents; Candida glabrata; Drug Synergism; Echinocandins; Humans; Lipopeptides; Macrophages; Micafungin; Microbial Sensitivity Tests; Microbial Viability; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2011 |
Combination antifungal therapy for invasive pulmonary aspergillosis in a heart transplant recipient.
Topics: Antifungal Agents; Drug Therapy, Combination; Echinocandins; Heart Transplantation; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Micafungin; Middle Aged; Pyrimidines; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2011 |
In vitro activity of E1210, a novel antifungal, against clinically important yeasts and molds.
Topics: Aminopyridines; Amphotericin B; Antifungal Agents; Aspergillus; Candida; Cell Line; Echinocandins; Fluconazole; Fungi; Fusarium; Humans; Isoxazoles; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Paecilomyces; Pseudallescheria; Pyrimidines; Scedosporium; Triazoles; Voriconazole; Yeasts | 2011 |
Antifungal susceptibilities of Aspergillus fumigatus clinical isolates obtained in Nagasaki, Japan.
Topics: Amino Acid Substitution; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Echinocandins; Female; Fungal Proteins; Humans; Itraconazole; Japan; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Mutation; Pyrimidines; Sequence Analysis, DNA; Triazoles; Voriconazole | 2012 |
Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species.
Topics: Amplified Fragment Length Polymorphism Analysis; Antifungal Agents; Bacterial Typing Techniques; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pseudallescheria; Pyrimidines; Scedosporium; Species Specificity; Triazoles; Voriconazole | 2012 |
Expression turnover profiling to monitor the antifungal activities of amphotericin B, voriconazole, and micafungin against Aspergillus fumigatus.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Echinocandins; Fungal Proteins; Gene Expression Profiling; Gene Expression Regulation, Fungal; Humans; Lipopeptides; Micafungin; Pyrimidines; RNA, Messenger; Transcriptome; Treatment Outcome; Triazoles; Voriconazole | 2012 |
The activity of echinocandins, amphotericin B and voriconazole against fluconazole-susceptible and fluconazole-resistant Brazilian Candida glabrata isolates.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida glabrata; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
A targeted peritransplant antifungal strategy for the prevention of invasive fungal disease after lung transplantation: a sequential cohort analysis.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Cohort Studies; Echinocandins; Female; Humans; Lipopeptides; Lung Transplantation; Male; Micafungin; Middle Aged; Mycoses; Risk; Time Factors; Triazoles | 2012 |
In vitro activities of nine antifungal drugs against 81 Phialophora and Cyphellophora isolates.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Nitriles; Phialophora; Pyridines; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2012 |
Pulmonary mucormycosis: what is the best strategy for therapy?
Topics: Acute Kidney Injury; Adult; Amphotericin B; Antifungal Agents; Debridement; Echinocandins; Humans; Lipopeptides; Lung Diseases, Fungal; Male; Micafungin; Mucormycosis; Pneumonectomy; Triazoles | 2013 |
[Infectious diseases: progress in diagnosis and treatment. Topics: IV. Towards containing infectious diseases: 3. Development of new antifungal drugs].
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Humans; Itraconazole; Lipopeptides; Micafungin; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2012 |
Invasive sino-orbital mycosis in an aplastic anemia patient caused by Neosartorya laciniosa.
Topics: Aged; Anemia, Aplastic; Antifungal Agents; Debridement; DNA, Fungal; Echinocandins; Eye Enucleation; Fungal Proteins; Humans; Lipopeptides; Male; Micafungin; Molecular Sequence Data; Mycoses; Neosartorya; Orbital Diseases; Phylogeny; Pyrimidines; Sequence Analysis, DNA; Sequence Homology; Sinusitis; Triazoles; Voriconazole | 2013 |
Invasive pulmonary aspergillosis due to Emericella nidulans var. echinulata, successfully cured by voriconazole and micafungin.
Topics: Aged; Antifungal Agents; DNA, Fungal; Echinocandins; Emericella; Exudates and Transudates; Galactose; Glucocorticoids; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Mannans; Micafungin; Microscopy; Molecular Sequence Data; Pyrimidines; Sequence Analysis, DNA; Treatment Outcome; Triazoles; Voriconazole | 2013 |
In vitro antifungal susceptibility of Cladophialophora carrionii, an agent of human chromoblastomycosis.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Caspofungin; Chromoblastomycosis; Echinocandins; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole | 2013 |
Comparison of four reading methods of broth microdilution based on the clinical and laboratory standards institute M27-A3 method for Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Itraconazole; Lipopeptides; Micafungin; Miconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
In vitro activities of eight antifungal drugs against 106 waterborne and cutaneous exophiala species.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Exophiala; Fluconazole; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole | 2013 |
Aspergillus tubingenesis endophthalmitis after cataract surgery with implantation of preloaded intraocular lens.
Topics: Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus; Device Removal; Drug Therapy, Combination; Echinocandins; Endophthalmitis; Eye Infections, Fungal; Humans; Intravitreal Injections; Lens Implantation, Intraocular; Lipopeptides; Male; Micafungin; Phacoemulsification; Postoperative Complications; Pyrimidines; Triazoles; Visual Acuity; Vitrectomy; Voriconazole | 2014 |
Disseminated pulmonary penicilliosis in a rheumatoid arthritis patient.
Topics: Amphotericin B; Anti-Inflammatory Agents; Antifungal Agents; Arthritis, Rheumatoid; Diagnosis, Differential; Echinocandins; Humans; Hydrocortisone; Lipopeptides; Lung; Lung Diseases, Fungal; Male; Micafungin; Middle Aged; Pyrimidines; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2014 |
Severe infections in children with acute leukemia undergoing intensive chemotherapy can successfully be prevented by ciprofloxacin, voriconazole, or micafungin prophylaxis.
Topics: Adolescent; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Agents; Child; Child, Preschool; Ciprofloxacin; Cohort Studies; Drug Costs; Echinocandins; Female; Humans; Infant; Leukemia, Myeloid, Acute; Lipopeptides; Male; Micafungin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Sepsis; Triazoles; Voriconazole | 2014 |
Assessing micafungin/triazole combinations for the treatment of invasive scedosporiosis due to Scedosporium apiospermum and Scedosporium boydii.
Topics: Animals; Antifungal Agents; Drug Therapy, Combination; Echinocandins; Lipopeptides; Male; Micafungin; Mice; Microbial Sensitivity Tests; Mycoses; Random Allocation; Scedosporium; Triazoles | 2014 |
Primary antifungal prophylaxis with micafungin in patients with haematological malignancies: real-life data from a retrospective single-centre observational study.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Administration Schedule; Echinocandins; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Injections, Intravenous; Lipopeptides; Male; Micafungin; Middle Aged; Retrospective Studies; Transplantation, Homologous; Triazoles; Trichosporon; Trichosporonosis | 2015 |
In vitro combination of isavuconazole with micafungin or amphotericin B deoxycholate against medically important molds.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Cunninghamella; Deoxycholic Acid; Drug Combinations; Drug Interactions; Echinocandins; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mucormycosis; Nitriles; Pyridines; Triazoles | 2014 |
Keratitis by Fusarium temperatum, a novel opportunist.
Topics: Amphotericin B; Antifungal Agents; Base Sequence; DNA, Fungal; Echinocandins; Fungal Proteins; Fusarium; Humans; Keratitis; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Molecular Sequence Data; Multilocus Sequence Typing; Mycoses; Phylogeny; Sequence Analysis, DNA; Treatment Outcome; Triazoles; Tubulin; Zea mays | 2014 |
Micafungin alone and in combination therapy with deferasirox against Pythium insidiosum.
Topics: Animals; Antifungal Agents; Benzoates; Deferasirox; Disease Models, Animal; Drug Therapy, Combination; Echinocandins; Female; Horse Diseases; Horses; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pythiosis; Pythium; Rabbits; Triazoles | 2015 |
Isavuconazole, micafungin, and 8 comparator antifungal agents' susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints and prop
Topics: Antifungal Agents; Drug Resistance, Fungal; Echinocandins; Fungi; Global Health; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mycoses; Nitriles; Opportunistic Infections; Pyridines; Triazoles | 2015 |
In Vitro Activities of Eight Antifungal Drugs against a Global Collection of Genotyped Exserohilum Isolates.
Topics: Amphotericin B; Amplified Fragment Length Polymorphism Analysis; Antifungal Agents; Ascomycota; Caspofungin; Echinocandins; Fluconazole; Genotype; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Molecular Sequence Data; Nitriles; Pyridines; Triazoles; Voriconazole | 2015 |
Laryngotracheal mucormycosis: Report of a case.
Topics: Antifungal Agents; Burkitt Lymphoma; Debridement; Dysphonia; Echinocandins; Hepatitis C, Chronic; HIV Infections; Humans; Hyperbaric Oxygenation; Laryngitis; Laryngoscopy; Lipopeptides; Male; Micafungin; Middle Aged; Mucormycosis; Neurosyphilis; Respiratory Distress Syndrome; Respiratory Sounds; Tracheitis; Tracheotomy; Triazoles | 2016 |
[NEW ANTIFUNGAL DRUGS FOR PREVENTION AND TREATMENT OF VISCERAL MYCOSES].
Topics: Antifungal Agents; Caspofungin; Drug Therapy; Echinocandins; Humans; Lipopeptides; Micafungin; Mycoses; Nitriles; Pyridines; Treatment Outcome; Triazoles; Voriconazole | 2015 |
Inhibitory Potential of Antifungal Drugs on ATP-Binding Cassette Transporters P-Glycoprotein, MRP1 to MRP5, BCRP, and BSEP.
Topics: Amphotericin B; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Echinocandins; Fluconazole; HEK293 Cells; Humans; Itraconazole; Lipopeptides; Micafungin; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Triazoles; Voriconazole | 2016 |
A cohort study on breakthrough invasive fungal infections in high-risk patients receiving antifungal prophylaxis.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Chemoprevention; Cohort Studies; Echinocandins; Female; Hematologic Diseases; Humans; Incidence; Invasive Fungal Infections; Itraconazole; Lipopeptides; Male; Micafungin; Middle Aged; Triazoles; Young Adult | 2016 |
Monotherapy or combination therapy of isavuconazole and micafungin for treating murine mucormycosis.
Topics: Animals; Antifungal Agents; Drug Therapy, Combination; Echinocandins; Lipopeptides; Lung; Male; Micafungin; Mice; Microbial Sensitivity Tests; Mucor; Mucormycosis; Nitriles; Pyridines; Rhizopus; Triazoles | 2017 |
In vitro combination therapy with isavuconazole against Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis, Invasive; Drug Synergism; Echinocandins; In Vitro Techniques; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Nitriles; Pyridines; Time Factors; Triazoles | 2017 |
Changing epidemiology of candidaemia in Australia.
Topics: Anidulafungin; Antifungal Agents; Australia; Azoles; Candida; Candida glabrata; Candida tropicalis; Candidemia; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Humans; Incidence; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Sequence Analysis, DNA; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Triazoles; Voriconazole | 2017 |
Combination Therapy with Isavuconazole and Micafungin for Treatment of Experimental Invasive Pulmonary Aspergillosis.
Topics: Animals; Antifungal Agents; Combined Modality Therapy; Echinocandins; Female; Galactose; Glucans; Invasive Pulmonary Aspergillosis; Lipopeptides; Lung; Mannans; Micafungin; Nitriles; Pyridines; Rabbits; Triazoles | 2017 |
Topics: Antifungal Agents; Candida; Caspofungin; Drug Interactions; Drug Resistance, Multiple, Fungal; Echinocandins; Fluconazole; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2017 |
Topics: Anidulafungin; Antifungal Agents; Aspergillus flavus; Aspergillus fumigatus; Aspergillus nidulans; Aspergillus niger; Drug Combinations; Drug Resistance, Fungal; Humans; Micafungin; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles | 2018 |
Successful Treatment of Lung Aspergillus terreus Infection After a Second Hematopoietic Stem Cell Transplant in a Patient With Myelodysplastic Syndrome.
Topics: Antifungal Agents; Hematopoietic Stem Cell Transplantation; Humans; Male; Micafungin; Myelodysplastic Syndromes; Postoperative Complications; Pulmonary Aspergillosis; Remission Induction; Triazoles; Young Adult | 2019 |
Subtherapeutic posaconazole troughs despite high-dose posaconazole tablets in a patient with terminal ileum resection.
Topics: Humans; Ileum; Leukemia; Micafungin; Myelodysplastic Syndromes; Tablets; Triazoles | 2019 |
Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candidemia; Caspofungin; Child; Child, Preschool; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Triazoles; Voriconazole; Young Adult | 2019 |
Rhizopus Infection in a Preterm Infant: A Novel Use of Posaconazole.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Humans; Infant, Newborn; Infant, Premature; Male; Micafungin; Microbial Sensitivity Tests; Mucormycosis; Rhizopus; Triazoles | 2020 |
Successful treatment of angioinvasive aspergillosis causing diaphragmatic rupture with bowel perforation and cerebral aspergillosis in a patient with FLT3-mutated acute myeloid leukemia: A case report.
Topics: Adult; Antifungal Agents; fms-Like Tyrosine Kinase 3; Humans; Intestinal Perforation; Invasive Pulmonary Aspergillosis; Leukemia, Myeloid, Acute; Male; Micafungin; Pyrimidines; Thoracic Injuries; Triazoles; Voriconazole | 2022 |
A case of drug-induced myopathy in alcoholic cirrhosis caused by voriconazole.
Topics: Aged; Antifungal Agents; Humans; Liver Cirrhosis, Alcoholic; Micafungin; Triazoles; Voriconazole | 2023 |